全文获取类型
收费全文 | 5642篇 |
免费 | 438篇 |
国内免费 | 86篇 |
专业分类
耳鼻咽喉 | 80篇 |
儿科学 | 258篇 |
妇产科学 | 102篇 |
基础医学 | 712篇 |
口腔科学 | 104篇 |
临床医学 | 694篇 |
内科学 | 1151篇 |
皮肤病学 | 218篇 |
神经病学 | 387篇 |
特种医学 | 510篇 |
外科学 | 599篇 |
综合类 | 106篇 |
一般理论 | 4篇 |
预防医学 | 487篇 |
眼科学 | 71篇 |
药学 | 341篇 |
2篇 | |
中国医学 | 11篇 |
肿瘤学 | 329篇 |
出版年
2022年 | 29篇 |
2021年 | 67篇 |
2020年 | 43篇 |
2019年 | 64篇 |
2018年 | 95篇 |
2017年 | 74篇 |
2016年 | 70篇 |
2015年 | 100篇 |
2014年 | 125篇 |
2013年 | 192篇 |
2012年 | 222篇 |
2011年 | 227篇 |
2010年 | 207篇 |
2009年 | 196篇 |
2008年 | 205篇 |
2007年 | 243篇 |
2006年 | 212篇 |
2005年 | 213篇 |
2004年 | 177篇 |
2003年 | 140篇 |
2002年 | 157篇 |
2001年 | 144篇 |
2000年 | 126篇 |
1999年 | 126篇 |
1998年 | 168篇 |
1997年 | 193篇 |
1996年 | 166篇 |
1995年 | 135篇 |
1994年 | 139篇 |
1993年 | 128篇 |
1992年 | 114篇 |
1991年 | 101篇 |
1990年 | 139篇 |
1989年 | 143篇 |
1988年 | 127篇 |
1987年 | 114篇 |
1986年 | 124篇 |
1985年 | 118篇 |
1984年 | 88篇 |
1983年 | 53篇 |
1982年 | 53篇 |
1981年 | 55篇 |
1980年 | 40篇 |
1979年 | 43篇 |
1978年 | 33篇 |
1977年 | 47篇 |
1976年 | 55篇 |
1975年 | 39篇 |
1973年 | 32篇 |
1970年 | 30篇 |
排序方式: 共有6166条查询结果,搜索用时 15 毫秒
81.
Sara Naimimohasses Philip OGorman Ciara Wright Deirdre Ni Fhloinn Dean Holden Niall Conlon Ann Monaghan Megan Kennedy John Gormley Peter Beddy Stephen Patrick Finn Joanne Lysaght Jacintha OSullivan Margaret R. Dunne Suzanne Norris J. Bernadette Moore 《Nutrients》2022,14(11)
Background: Mucosal-associated invariant T (MAIT) cells promote inflammation in obesity and are implicated in the progression of non-alcoholic fatty liver disease (NAFLD). However, as the intrahepatic MAIT cell response to lifestyle intervention in NAFLD has not been investigated, this work aimed to examine circulating and intrahepatic MAIT cell populations in patients with NAFLD, after either 12 weeks of dietary intervention (DI) or aerobic exercise intervention (EI). Methods: Multicolour flow cytometry was used to immunophenotype circulating and intrahepatic MAIT cells and measure MAIT cell expression (median fluorescence intensity, MFI) of the activation marker CD69 and apoptotic marker CD95. Liver histology, clinical parameters, and MAIT cell populations were assessed at baseline (T0) and following completion (T1) of DI or EI. Results: Forty-five patients completed the study. DI participants showed decreased median (interquartile range) expression of the activation marker CD69 on circulating MAIT cells (T0: 104 (134) versus T1 27 (114) MFI; p = 0.0353) and improvements in histological steatosis grade post-intervention. EI participants showed increased expression of the apoptotic marker CD95, both in circulating (T0: 1549 (888) versus T1: 2563 (1371) MFI; p = 0.0043) and intrahepatic MAIT cells (T0: 2724 (862) versus T1: 3117 (1622) MFI; p = 0.0269). Moreover, the percentage of intrahepatic MAIT cells significantly decreased after EI (T0: 11.1 (14.4) versus T1: 5.3 (9.3)%; p = 0.0029), in conjunction with significant improvements in fibrosis stage and hepatocyte ballooning. Conclusions: These data demonstrate independent benefits from dietary and exercise intervention and suggest a role for intrahepatic MAIT cells in the observed histological improvements in NAFLD. 相似文献
82.
83.
BackgroundThere are few data on the bronchodilatory effects of adding short-acting bronchodilators (SABA) to maintenance, long-acting bronchodilator therapy. This study assessed the additional bronchodilation and safety of adding supratherapeutic doses of salbutamol (SALB) or ipratropium bromide (IPR) to the novel bi-functional molecule (or dual pharmacophore) GSK961081 400 μg (MABA 400) or 1200 μg (MABA 1200).MethodsThis randomised, double-blind, complete, crossover study in 44 patients with moderate to severe COPD, evaluated 6 treatments with a washout of at least 7 days between treatments: single doses of MABA 400 or MABA 1200 followed by cumulative doses of either SALB (3× 200 μg at 20 min intervals), IPR (20 μg, 20 μg and 40 μg at 20 min intervals) or placebo (PLA) (three doses at 20 min intervals) at 1 h, 12 h and 24 h post-MABA dose. The primary endpoint was maximal increase in FEV1, from pre-dose bronchodilator (SABA/PLA), measured 15 min after each cumulative dose of SALB, IPR or PLA. Systemic pharmacodynamics (potassium, heart rate, glucose and QTc), adverse events and systemic pharmacokinetics were also assessed.ResultsThe additional bronchodilatory effects at 12 h and 24 h for both SALB and IPR were of a similar magnitude and statistically significant relative to PLA; mean differences (SE) (L) following MABA 400 dosing: 0.139 (0.023) after SALB at 12 h; 0.123 (0.022) after SALB at 24 h; 0.124 (0.023) after IPR at 12 h; 0.141 (0.021) after IPR at 24 h; and after MABA 1200 dosing: 0.091 (0.023) after SALB at 12 h; 0.126 (0.022) after SALB at 24 h; 0.055 (0.023) after IPR at 12 h; 0.122 (0.022) after IPR at 24 h. Any additional bronchodilator effects at 1 h were small and not clinically significantly different from PLA. There were small, non-clinically significant increases in mean heart rate after both MABA doses plus SALB, and decreased potassium levels in four patients after MABA 1200 plus SALB (×3) or PLA (×1) were observed but overall all treatments were well tolerated and raised no significant safety signals.ConclusionThe additional bronchodilation achieved following supratherapeutic doses of SALB and IPR on top of single doses of MABA 400 or 1200 was comparable for the two agents and neither were associated with any clinically relevant systemic pharmacodynamic effects other than the small transient hypokalemic effect in a 3 out of 41 patients receiving additional high dose salbutamol and MABA 1200. Either short-acting bronchodilator could potentially be used as rescue medication on top of MABA therapy. 相似文献
84.
Past research provides evidence for trajectories of health and wellness among individuals following disasters that follow specific pathways of resilience, resistance, recovery, or continued dysfunction. These individual responses are influenced by event type and pre-event capacities. This study was designed to utilize the trajectories of health model to determine if it translates to population health. We identified terrorist attacks that could potentially impact population health rather than only selected individuals within the areas of the attacks. We chose to examine a time series of population birth outcomes before and after the terrorist events of the New York City (NYC) World Trade Center (WTC) attacks of 2001 and the Madrid, Spain train bombings of 2004 to determine if the events affected maternal–child health of those cities and, if so, for how long. For percentages of low birth weight (LBW) and preterm births, we found no significant effects from the WTC attacks in NYC and transient but significant effects on rates of LBW and preterm births following the bombings in Madrid. We did find a significant positive and sustained effect on infant mortality rate in NYC following the WTC attacks but no similar effect in Madrid. There were no effects on any of the indicator variables in the comparison regions of New York state and the remainder of Spain. Thus, population maternal–health in New York and Madrid showed unique adverse effects after the terrorist attacks in those cities. Short-term effects on LBW and preterm birth rates in Madrid and long-term effects on infant mortality rates in NYC were found when quarterly data were analyzed from 1990 through 2008/2009. These findings raise questions about chronic changes in the population’s quality of life following catastrophic terrorist attacks. Public health should be monitored and interventions designed to address chronic stress, environmental, and socioeconomic threats beyond the acute aftermath of events. 相似文献
85.
86.
87.
88.
89.
90.
Nonpalpable breast lesions: recommendations for biopsy based on suspicion of carcinoma at mammography 总被引:12,自引:0,他引:12
Carcinoma was found in 30% (119 of 400) of biopsy specimens obtained for mammographically suspicious but nonpalpable findings. The authors reviewed the mammograms of these 400 cases without knowledge of the biopsy results and placed each examination into one of four groups based on their suspicion for carcinoma: minimal (n = 82), slight (n = 91), moderate (n = 174), and high (n = 53). In 127 cases, mammograms showed either minimally suspicious calcifications (n = 33) or minimally (n = 49) or slightly (n = 45) suspicious masses. A 4.7% (six of 127) rate of carcinoma was found in these groups; five of the six cancers were in situ. Had follow-up mammography been done rather than biopsy for these 127 less suspicious lesions, it is probable that the delay in diagnosis would not have altered overall prognosis. In the remaining 273 patients, the positive predictive value of mammography for carcinoma would have risen from 30% (119 of 400) to 41% (113 of 273). The authors conclude that in the management of suspicious nonpalpable mammographic findings, the rate of carcinoma for lesions at biopsy can approximate 40%. This is almost double the rate of most published series. 相似文献